Journal issues > Issue 3, May 2019 > Rebuttal to “The role of direct oral anticoagulants in the management of cancer-associated thrombosis’

Rebuttal to “The role of direct oral anticoagulants in the management of cancer-associated thrombosis’

By: M. Schapira MD

Concerning the review published in BJMO issue 2, March 2019:

The role of direct oral anticoagulants in the management of cancer-associated thrombosis

A. Awada, J-F. Baurain, P. Clement, P. Hainaut, S. Holbrechts, K. Jochmans, V. Mathieux, J. Mebis, M. Strijbos, C. Vulsteke, T. Vanassche, P. Verhamme (BELG J MED ONCOL 2019;13(2):46-53)

(BELG J MED ONCOL 2019;13(3):83)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top